Ton Lisman Selected Research

End Stage Liver Disease

1/2023	Clinically relevant increases in the international normalized ratio and model of end-stage liver disease score by therapeutic doses of direct oral anticoagulants in patients with cirrhosis.
9/2020	Anticoagulant Management and Synthesis of Hemostatic Proteins during Machine Preservation of Livers for Transplantation.
9/2020	In Vitro Evaluation of Pro- and Anticoagulant Drugs in Children with End-Stage Liver Disease Undergoing Liver Transplantation.
1/2020	Evidence for a rebalanced hemostatic system in pediatric liver transplantation: A prospective cohort study.
1/2019	Plasma From Patients Undergoing Liver Transplantation Is Resistant to Anticoagulant Activity of Soluble Thrombomodulin.
12/2008	Interlaboratory variability in assessment of the model of end-stage liver disease score.
6/2008	The two tales of coagulation in liver transplantation.
1/2007	Hemostatic alterations in liver disease: a review on pathophysiology, clinical consequences, and treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ton Lisman Research Topics

Disease

55	Fibrosis (Cirrhosis) 03/2024 - 03/2002
54	Liver Diseases (Liver Disease) 04/2024 - 07/2006
52	Hemorrhage 04/2024 - 03/2002
37	Thrombosis (Thrombus) 01/2023 - 03/2006
9	Thrombocytopenia (Thrombopenia) 10/2022 - 02/2008
9	Thrombophilia 01/2022 - 02/2005
8	Acute-On-Chronic Liver Failure 12/2023 - 09/2020
8	Inflammation (Inflammations) 05/2023 - 07/2009
8	Acute Liver Failure (Fulminant Hepatic Failure) 01/2023 - 06/2010
8	End Stage Liver Disease 01/2023 - 01/2007
8	COVID-19 10/2021 - 10/2020
7	Hemophilia A (Haemophilia) 04/2024 - 01/2002
7	Venous Thrombosis (Deep-Vein Thrombosis) 10/2021 - 05/2007
6	Portal Hypertension 12/2023 - 01/2007
5	Neoplasms (Cancer) 05/2023 - 09/2004
5	Liver Cirrhosis (Hepatic Cirrhosis) 01/2017 - 03/2007
5	Pathologic Constriction (Stenosis) 01/2015 - 08/2011
4	Venous Thromboembolism 10/2023 - 07/2008
4	Wounds and Injuries (Trauma) 04/2023 - 03/2017
4	Hepatic Encephalopathy 03/2022 - 04/2016
4	Myocardial Infarction 10/2021 - 06/2009
4	Reperfusion Injury 09/2021 - 08/2012
4	Ischemia 01/2019 - 08/2011
4	Non-alcoholic Fatty Liver Disease 02/2017 - 01/2015
3	Chronic Kidney Failure (Chronic Renal Failure) 05/2024 - 01/2019
3	Fatty Liver 11/2023 - 09/2015
3	Cardiovascular Diseases (Cardiovascular Disease) 10/2023 - 11/2007
3	Sepsis (Septicemia) 10/2023 - 06/2010
3	von Willebrand Diseases (von Willebrand's Disease) 05/2023 - 03/2007
3	Leg Injuries (Leg Injury) 04/2023 - 01/2022
3	Liver Failure 01/2023 - 08/2010
3	Disease Progression 01/2022 - 01/2015
3	Critical Illness (Critically Ill) 01/2022 - 01/2021
3	Disease Susceptibility (Diathesis) 01/2014 - 03/2002
3	Thrombasthenia (Glanzmann Thrombasthenia) 04/2008 - 03/2003
2	Brain Death (Brain Dead) 02/2024 - 01/2022
2	Atrial Fibrillation 09/2023 - 01/2023
2	Thrombotic Microangiopathies 05/2023 - 01/2015
2	Thromboembolism 05/2023 - 01/2014
2	Necrosis 01/2023 - 01/2019
2	Pulmonary Embolism 10/2021 - 08/2004
2	Disseminated Intravascular Coagulation 01/2019 - 03/2017
2	Obesity 11/2016 - 06/2016

Drug/Important Bio-Agent (IBA)

63	Hemostatics (Antihemorrhagics)IBA 04/2024 - 07/2006
39	AnticoagulantsIBA 03/2024 - 03/2006
27	Thrombin FDA Link 04/2023 - 04/2008
22	von Willebrand FactorIBA 12/2023 - 07/2006
18	Proteins (Proteins, Gene)FDA Link 01/2023 - 07/2006
12	Heparin (Liquaemin)FDA LinkGeneric 10/2021 - 08/2004
11	Fibrinogen (Factor I)FDA Link 11/2023 - 06/2016
10	FibrinIBA 11/2023 - 05/2007
9	recombinant FVIIa (rFVIIa)FDA Link 11/2020 - 01/2002
8	Blood Coagulation Factors (Coagulation Factor)IBA 04/2024 - 07/2008
8	fibrin fragment D (D-dimer)IBA 01/2023 - 01/2017
8	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2021 - 08/2004
7	AntigensIBA 12/2023 - 07/2006
7	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2023 - 08/2005
7	Carboxypeptidase B2 (Thrombin Activatable Fibrinolysis Inhibitor)IBA 01/2023 - 01/2002
7	Factor VIII (Coagulation Factor VIII)IBA 05/2022 - 06/2010
6	Prothrombin (Factor II)IBA 06/2023 - 07/2013
6	PlasminogenIBA 01/2023 - 05/2007
6	Antifibrinolytic Agents (Antifibrinolytics)IBA 01/2023 - 06/2008
6	ThrombomodulinIBA 01/2022 - 08/2005
5	AntithrombinsIBA 01/2023 - 12/2013
5	Thromboplastin (Tissue Factor)IBA 07/2022 - 09/2004
5	nasIBA 01/2015 - 08/2011
4	Plasminogen Activator Inhibitor 1IBA 01/2023 - 07/2009
4	Fibrinolysin FDA Link 01/2023 - 01/2015
3	edoxabanIBA 03/2024 - 01/2020
3	Factor XIII (Coagulation Factor XIII)IBA 11/2023 - 09/2011
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 09/2004
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 09/2019
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 09/2019
3	Vitamin K FDA Link 01/2022 - 01/2019
3	Oral ContraceptivesIBA 01/2022 - 05/2008
3	Plasminogen Activators (Plasminogen Activator)IBA 01/2017 - 05/2007
3	CollagenIBA 06/2010 - 07/2006
2	Dabigatran FDA Link 03/2024 - 01/2014
2	apixabanIBA 03/2024 - 04/2015
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2023 - 07/2013
2	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2023 - 01/2020
2	Protein CIBA 01/2023 - 01/2023
2	lipoprotein-associated coagulation inhibitor (TFPI)IBA 01/2023 - 09/2013
2	Factor VIIa (Activated Factor VII)IBA 01/2023 - 04/2008
2	Protein SIBA 01/2023 - 09/2013
2	AutoantibodiesIBA 05/2022 - 02/2021
2	Thiobarbituric Acid Reactive SubstancesIBA 01/2022 - 09/2019
2	Cell-Free Nucleic AcidsIBA 01/2022 - 09/2019
2	dicarboxydine (DCD)IBA 01/2022 - 10/2015
2	ThrombospondinsIBA 01/2021 - 01/2015
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 01/2015

Therapy/Procedure

36	Liver Transplantation 11/2023 - 03/2002
17	Therapeutics 10/2023 - 07/2013
10	Transplantation 05/2024 - 08/2013
6	Hepatectomy 11/2023 - 01/2015
4	Kidney Transplantation 05/2024 - 01/2018
3	Platelet Transfusion (Blood Platelet Transfusions) 01/2021 - 07/2008
2	Contraindications 10/2022 - 11/2021
2	Critical Care (Surgical Intensive Care) 03/2022 - 07/2019
2	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2021 - 04/2016